Randall Michael Giuffre - Net Worth and Insider Trading
Randall Michael Giuffre Net Worth
The estimated net worth of Randall Michael Giuffre is at least $1 Million dollars as of 2024-05-23. Randall Michael Giuffre is the Director of DiaMedica Therapeutics Inc and owns about 391,998 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $1 Million. Details can be seen in Randall Michael Giuffre's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randall Michael Giuffre has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).
Transaction Summary of Randall Michael Giuffre
Randall Michael Giuffre Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall Michael Giuffre owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Randall Michael Giuffre’s form 4 insider trades.
Insider Ownership Summary of Randall Michael Giuffre
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | director |
Randall Michael Giuffre Latest Holdings Summary
Randall Michael Giuffre currently owns a total of 1 stock. Randall Michael Giuffre owns 391,998 shares of DiaMedica Therapeutics Inc (DMAC) as of June 23, 2023, with a value of $1 Million.
Latest Holdings of Randall Michael Giuffre
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | 391,998 | 2.83 | 1,107,394 |
Holding Weightings of Randall Michael Giuffre
Randall Michael Giuffre Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall Michael Giuffre has made a total of 6 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 65,000 shares on June 23, 2023, which cost Randall Michael Giuffre around $254,150.
Insider Trading History of Randall Michael Giuffre
- 1
Randall Michael Giuffre Trading Performance
GuruFocus tracks the stock performance after each of Randall Michael Giuffre's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall Michael Giuffre is 35.28%. GuruFocus also compares Randall Michael Giuffre's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall Michael Giuffre within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randall Michael Giuffre's insider trading performs compared to the benchmark.
Performance of Randall Michael Giuffre
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.57 | | | | | |
| Relative Return to S&P 500(%) | 20.52 | | | | | |
Randall Michael Giuffre Ownership Network
Randall Michael Giuffre Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Randall Michael Giuffre is the director of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , 10 percent owner Jan Stahlberg , and 10 percent owner Ab Trill .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Randall Michael Giuffre made 5 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 215,000. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 1,470,588 shares made by Koch Thomas Von , a net purchase of 527,114 shares made by David J. Wambeke , and a net purchase of 73,363 shares made by Richard D. Pilnik .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Randall Michael Giuffre Mailing Address
Above is the net worth, insider trading, and ownership report for Randall Michael Giuffre. You might contact Randall Michael Giuffre via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
